Call Options Transactions Made in Q4 2023 in Ascendis Pharma A/S (ASND)
This table provides information about the institutional ownership of Ascendis Pharma A/S (ASND) during Q4 2023. The information is specifically focused on institutions that hold call options of Ascendis Pharma A/S.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
44K+ 127.54% |
$3.79M - $5.6M
|
78.5K
$9.89M
|
|
|
Feb 14, 2024
Q4 2023
|
Hap Trading, LLC
New York, NY |
BUY
|
CALL |
40KNew |
$3.44M - $5.09M
|
40K
$5.04M
|
|
|
Feb 14, 2024
Q4 2023
|
Gts Securities LLC
New York, NY |
BUY
|
CALL |
36.8KNew |
$3.17M - $4.69M
|
36.8K
$4.64M
|
|
|
Feb 15, 2024
Q4 2023
|
Barclays PLC
London, X0 |
BUY
|
CALL |
22.5KNew |
$1.94M - $2.87M
|
22.5K
$2.84M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
4.7K+ 25.13% |
$405K - $599K
|
23.4K
$2.95M
|
|
|
Feb 09, 2024
Q4 2023
|
Citigroup Inc
|
BUY
|
CALL |
3.2K+ 12.8% |
$276K - $408K
|
28.2K
$3.55M
|
|
|
Feb 14, 2024
Q4 2023
|
Walleye Trading LLC
Plymouth, MN |
BUY
|
CALL |
1.3K+ 86.67% |
$112K - $166K
|
2.8K
$353K
|
|
|
Feb 14, 2024
Q4 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
CALL |
-1.3K- 68.42% |
$112K - $166K
|
600
$75.6K
|